NCT06541522

Brief Summary

ARDS is a frequent reason for hospitalization in intensive care. In order to improve its management, doctors seek to limit the mechanical ventilation-induced injuries (VILI) that can occur. PEEP is a parameter that plays a role in the appearance of VILI, and its adjustment can be optimized by EIT. The EIT is a non-invasive, non-irradiating, real-time monitoring device, today widely used for the optimization of ventilation in patients intubated for ARDS. The positioning of the EIT belt at different chest heights could influence the result of the PEEP titration.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 30, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 7, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

November 21, 2024

Status Verified

November 1, 2024

Enrollment Period

1 year

First QC Date

July 30, 2024

Last Update Submit

November 19, 2024

Conditions

Keywords

ARDSmechanical ventilationEIT

Outcome Measures

Primary Outcomes (1)

  • Impact of the position of the electrode belt on the results of PEEP titration by EIT.

    Optimal PEEP determined by PEEP titration using the crossing point method.

    Day 0

Secondary Outcomes (3)

  • Impact of the existence of intra-tidal recruitment on the discordance between PEPEIT and PEPCRS

    Day 0

  • Factors associated with a discordance between PEPEIT and PEPCRS

    Day 0

  • Discrepancy between compliance measured according to impedance and compliance measured according to exhaled volume

    Day 0

Study Arms (1)

PEEP titrations

OTHER
Device: EIT

Interventions

EITDEVICE

Two PEEP titrations monitored by EIT will be performed, each with the electrode belt positioned at a different chest height (2nd intercostal space or 5th intercostal space). The order will be drawn at random.

PEEP titrations

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Occurrence of moderate to severe ARDS (PaO2/FiO2 ratio ≤ 200 mmHg) within 72 hours following intubation
  • Criteria for moderate to severe ARDS for less than 72 hours
  • Passive ventilation in controlled assisted ventilation (no spontaneous ventilation)
  • Consent of next of kin

You may not qualify if:

  • Age \< 18 years
  • ECMO
  • Pneumothorax
  • Pacemaker or implantable defibrillator
  • Chest trauma in the last 3 months
  • Skin peeling (Burned, Lyell)
  • Intracranial hypertension
  • Uncontrolled shock (noradrenaline \>5 mg/h)
  • Pregnant woman
  • Adult patient protected within the meaning of the law
  • Lack of social security

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: Once the patient is included in the research, two PEEP titrations monitored by EIT will be performed, each with the electrode belt positioned at a different chest height. The order will be drawn at random.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 30, 2024

First Posted

August 7, 2024

Study Start

January 1, 2025

Primary Completion

January 1, 2026

Study Completion

January 1, 2026

Last Updated

November 21, 2024

Record last verified: 2024-11